EGFR activation disrupts immunotherapy response via SHP2-mediated suppression of tumor-intrinsic response to IFN-γ

Journal:

Journal of Clinical Investigation

Published:

2026-01-15

DOI:

10.1172/jci194377

Affiliations:

6

Authors:

22

Go to article

Institutions	Authors	Share
State Key Laboratory of Oncology in South China, SYSUCC, China	14.000000 14.000000	0.64
The Fifth Affiliated Hospital, SYSU, China	3.000000	0.14
Guangdong Academy of Medical Sciences (Guangdong Provincial People’s Hospital), China	2.000000	0.09
MOE Key Laboratory of Tumor Molecular Biology, JNU, China	2.000000	0.09
State Key Laboratory of Respiratory Disease (SKLRD), China	0.500000	0.02
The First Affiliated Hospital of Xiamen University, China	0.500000	0.02

Interested in Oncology and Carcinogenesis?